Literature DB >> 23851425

The prevalence of abnormal metabolic parameters in obese and overweight children.

Deborah Salvatore1, Ava Satnick2, Rebecca Abell2, Catherine R Messina3, Anupama Chawla2.   

Abstract

BACKGROUND: This retrospective study aimed to determine the prevalence of abnormal metabolic parameters in obese children and its correlation to the degree of obesity determined by body mass index (BMI).
METHODS: In total, 101 children seen at the Pediatric Gastroenterology Obesity Clinic at Stony Brook Children's University Hospital were enrolled in the study. The degree of obesity was characterized according to the following formula: (patient's BMI/BMI at 95th percentile) × 100%, with class I obesity >100%-120%, class II obesity >120%-140%, and class III obesity >140%. A set of metabolic parameters was evaluated in these patients. Frequency distributions of all study variables were examined using the χ(2) test of independence. Mean differences among the obesity classes and continuous measures were examined using 1-way analysis of variance.
RESULTS: Within our study population, we found that 80% of our obese children had a low high-density lipoprotein (HDL) cholesterol level, 58% had elevated fasting insulin levels, and 32% had an elevated alanine aminotransferase (ALT) level. Class II obese children had a 2-fold higher ALT value when compared with class I children (P = .036). Fasting insulin, ALT, HDL cholesterol, and triglyceride levels trended with class of obesity.
CONCLUSION: Obese children in classes II and III are at higher risk for developing abnormal laboratory values. We recommend obese children be further classified to reflect the severity of the obesity since this has predictive significance for comorbidities. Obesity classes I, II, and III could help serve as a screening tool to help communicate risk assessment.
© 2013 American Society for Parenteral and Enteral Nutrition.

Entities:  

Keywords:  nutrition assessment; obesity; pediatrics

Mesh:

Substances:

Year:  2013        PMID: 23851425     DOI: 10.1177/0148607113496820

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  5 in total

1.  Serum 25-Hydroxyvitamin D associated with indicators of body fat and insulin resistance in prepubertal chilean children.

Authors:  G Cediel; C Corvalán; C Aguirre; D L de Romaña; R Uauy
Journal:  Int J Obes (Lond)       Date:  2015-08-12       Impact factor: 5.095

Review 2.  Impact of DHA on metabolic diseases from womb to tomb.

Authors:  Ilse A C Arnoldussen; Amanda J Kiliaan
Journal:  Mar Drugs       Date:  2014-12-18       Impact factor: 5.118

3.  Obesity Cardiometabolic Comorbidity Prevalence in Children in a Rural Weight-Management Program.

Authors:  Valerie O'Hara; Nancy Browne; Samreen Fathima; Barbara Sorondo; Janet Bayleran; Starr Johnston; Kathrin Hastey
Journal:  Glob Pediatr Health       Date:  2017-09-08

4.  Health-Related Quality of Life across Recent Pediatric Obesity Classification Recommendations.

Authors:  William R Black; Kelsey B Borner; Marshall T Beauchamp; Ann M Davis; Meredith L Dreyer Gillette; Brooke Sweeney; Sarah E Hampl
Journal:  Children (Basel)       Date:  2021-04-15

Review 5.  Adipose tissue immune response: novel triggers and consequences for chronic inflammatory conditions.

Authors:  Giorgio Ghigliotti; Chiara Barisione; Silvano Garibaldi; Patrizia Fabbi; Claudio Brunelli; Paolo Spallarossa; Paola Altieri; Gianmarco Rosa; Giovanni Spinella; Domenico Palombo; Razvan Arsenescu; Violeta Arsenescu
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.